Concise Prescribing Info
Listed in Dosage.
Dosage/Direction for Use
Adult : Mouth/throat Sore throat As loz: Up to 10 mg 2 hrly if needed. As spray: 3 sprays to the back of throat 2-3 hrly. Max: 8 doses/day. Surface anaesth of mouth and throat As gel, paste, spray or soln up to 20%: Apply up to 4 times/day. Topical Topical analgesia and anaesth As 5-20% spray, cream, oint, lotion, gel or soln: Apply 3-4 times/day.
Dosage Details
Surface anaesthesia of mouth and throat
Adult: As gel, paste, spray or soln up to 20%: Apply to affected area up to 4 times daily.

Sore throat
Adult: As loz: Up to 10 mg to be dissolved slowly in the mouth and repeated 2 hrly, as necessary. As spray: 3 sprays (3 mg) to the back of throat, repeat 2-3 hrly. Max: 8 doses daily.
Child: 6-12 yr As spray: 1 spray (1 mg) to the back of throat, repeat 2-3 hrly. Max: 8 doses daily.

Topical analgesia and anaesthesia
Adult: As 5-20% spray, cream, oint, lotion, gel or soln: Apply 3-4 times daily.
Epiglottis (oral spray), methaemoglobinaemia.
Special Precautions
Patient w/ asthma, bronchitis, emphysema, heart disease; smokers. Childn. Pregnancy and lactation.
Adverse Reactions
Localised burning or erythema, stinging sensation, contact dermatitis, rash, urticaria, methaemoglobinaemia, oedema, tenderness.
Monitor for signs and symptoms of methaemoglobinaemia.
Methaemoglobinaemia, manifested by cyanotic (greyish) skin discolouration, unusual breathing or breathlessness. Management: Symptomatic and supportive treatment. IV methylene blue 1% may be administered.
Drug Interactions
May antagonise the therapeutic effect of sulfonamides. Anticholinesterases may inhibit the metabolism benzocaine.
Description: Benzocaine, an ester local anaesthetic, blocks the initiation and conduction of nerve impulses by decreasing the neuronal membrane’s permeability to Na ions, which results in inhibition of depolarisation w/ resultant blockade of conduction.
Absorption: Well absorbed from mucous membranes and traumatised skin; poorly absorbed from intact skin.
Metabolism: Metabolised in the liver (lesser extent) and plasma via hydrolysis by cholinesterase.
Excretion: Via urine, as metabolites.
Chemical Structure

Click on icon to see table/diagram/image
Store between 15-30°C.
ATC Classification
N01BA05 - benzocaine ; Belongs to the class of esters of aminobenzoic acid. Used as local anesthetics.
R02AD01 - benzocaine ; Belongs to the class of local anesthetics used in throat preparations.
C05AD03 - benzocaine ; Belongs to the class of local anesthetics. Used in the topical treatment of hemorrhoids and anal fissures.
D04AB04 - benzocaine ; Belongs to the class of topical anesthetics used in the treatment of pruritus.
Disclaimer: This information is independently developed by MIMS based on Benzocaine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in